Invesco

Invesco Portfolio holdings

AUM $588B
1-Year Return 25.92%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Quarter Return
+0.71%
1 Year Return
+25.92%
3 Year Return
+99.18%
5 Year Return
+189.75%
10 Year Return
+417.35%
AUM
$255B
AUM Growth
-$3.63B
Cap. Flow
-$2.69B
Cap. Flow %
-1.05%
Top 10 Hldgs %
12.76%
Holding
4,482
New
462
Increased
1,845
Reduced
1,866
Closed
145

Sector Composition

1 Technology 15.71%
2 Healthcare 14.19%
3 Financials 13.69%
4 Communication Services 8.74%
5 Real Estate 8.29%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ATRA icon
4001
Atara Biotherapeutics
ATRA
$90.7M
$5K ﹤0.01%
+4
New +$5K
AXDX
4002
DELISTED
Accelerate Diagnostics
AXDX
$5K ﹤0.01%
+20
New +$5K
BCRX icon
4003
BioCryst Pharmaceuticals
BCRX
$1.74B
$5K ﹤0.01%
+362
New +$5K
BPMC
4004
DELISTED
Blueprint Medicines
BPMC
$5K ﹤0.01%
+177
New +$5K
CDTX icon
4005
Cidara Therapeutics
CDTX
$1.6B
$5K ﹤0.01%
+18
New +$5K
CERS icon
4006
Cerus
CERS
$255M
$5K ﹤0.01%
+983
New +$5K
CRDF icon
4007
Cardiff Oncology
CRDF
$144M
$5K ﹤0.01%
+7
New +$5K
DRRX icon
4008
DURECT Corp
DRRX
$59.3M
$5K ﹤0.01%
+222
New +$5K
ELDN icon
4009
Eledon Pharmaceuticals
ELDN
$162M
$5K ﹤0.01%
+2
New +$5K
EXEL icon
4010
Exelixis
EXEL
$10.2B
$5K ﹤0.01%
1,368
-2,215
-62% -$8.1K
IMUX icon
4011
Immunic
IMUX
$75.1M
$5K ﹤0.01%
+6
New +$5K
INO icon
4012
Inovio Pharmaceuticals
INO
$148M
$5K ﹤0.01%
+51
New +$5K
INSM icon
4013
Insmed
INSM
$30.7B
$5K ﹤0.01%
+225
New +$5K
INVA icon
4014
Innoviva
INVA
$1.29B
$5K ﹤0.01%
277
-798,900
-100% -$14.4M
IOVA icon
4015
Iovance Biotherapeutics
IOVA
$901M
$5K ﹤0.01%
+569
New +$5K
KALV icon
4016
KalVista Pharmaceuticals
KALV
$796M
$5K ﹤0.01%
+54
New +$5K
KPTI icon
4017
Karyopharm Therapeutics
KPTI
$57.2M
$5K ﹤0.01%
+13
New +$5K
LCTX icon
4018
Lineage Cell Therapeutics
LCTX
$279M
$5K ﹤0.01%
+1,643
New +$5K
LRMR icon
4019
Larimar Therapeutics
LRMR
$337M
$5K ﹤0.01%
+12
New +$5K
LXRX icon
4020
Lexicon Pharmaceuticals
LXRX
$396M
$5K ﹤0.01%
+680
New +$5K
MDGL icon
4021
Madrigal Pharmaceuticals
MDGL
$9.65B
$5K ﹤0.01%
+61
New +$5K
NG icon
4022
NovaGold Resources
NG
$2.75B
$5K ﹤0.01%
1,420
-23,091
-94% -$81.3K
NRC icon
4023
National Research Corp
NRC
$355M
$5K ﹤0.01%
+381
New +$5K
PTCT icon
4024
PTC Therapeutics
PTCT
$4.55B
$5K ﹤0.01%
105
-93,011
-100% -$4.43M
RARE icon
4025
Ultragenyx Pharmaceutical
RARE
$3.07B
$5K ﹤0.01%
+53
New +$5K